GLP-1 Drugs, Like Ozempic, May Offer New Hope for Addiction Treatment

A recent study sheds light on an unexpected benefit of GLP-1 agonist medications, commonly used for managing diabetes and weight loss. These drugs, such as Ozempic, may also reduce the risk of opioid overdose and alcohol intoxication in individuals with substance use disorders.

The research, published in Addiction, examined health data from 1.3 million people over a span of nearly nine years, gathered from 136 U.S. hospitals. Among those analyzed were 500,000 individuals with opioid use disorder and more than 800,000 with alcohol use disorder. The study found that people using GLP-1 drugs experienced significant reductions in risk—40% lower for opioid overdose and 50% lower for alcohol intoxication—compared to those who weren’t on these medications.

“It helps to underline another significant benefit of this class of medication,” said Dr. Angela Fitch, co-founder and chief medical officer at knownwell, a healthcare provider that promotes weight-inclusive care. Her comments emphasize the potential these drugs hold for addressing addiction, in addition to their established roles in diabetes and weight management.

The appeal of these medications, according to experts, stems from the fact that they offer a less stigmatized alternative for treating addiction. “The existing medications for treating substance use disorder are underutilized and stigmatized,” said Fares Qeadan, an associate professor of biostatistics at Loyola University in Chicago. He noted that medications like Ozempic, originally intended for diabetes and weight loss, offer a way to tackle addiction without the negative associations often attached to traditional treatments.

GLP-1 drugs work by mimicking a hormone in the body that helps regulate blood sugar and insulin. These medications also slow digestion and curb appetite, which aids in weight loss and managing diabetes. While the exact mechanism isn’t fully understood, some studies suggest that GLP-1 drugs may influence brain pathways involved in the reward system, possibly reducing cravings for substances like alcohol and opioids.

A previous study reinforced this theory, showing that adding the GLP-1 agonist exenatide helped people with obesity and alcohol use disorder reduce their drinking. However, the recent findings from Addiction don’t definitively prove a direct cause-and-effect relationship between GLP-1 drugs and reduced overdose or intoxication risk. The research focused solely on hospitalizations, so it remains unclear how the drugs might perform in less severe cases.

At present, GLP-1 drugs are not approved by the U.S. Food and Drug Administration (FDA) for treating addiction. Dr. Fitch highlighted this limitation, saying, “One of the challenges that we have as clinicians is we know that some of these benefits help patients. And not being able to get them access is very challenging.”

Substance use disorder, defined by the inability to stop using drugs or alcohol despite its harmful effects, continues to be a major public health issue. According to the Centers for Disease Control and Prevention (CDC), excessive alcohol use contributes to 178,000 deaths annually, while over 75% of drug overdose deaths in 2022 involved opioids.

Latest Petitions to Sign:

• Petition: Help Ensure People in Mental Health Crises Receive Help to Prevent Animal Abuse
• Petition: Tell Major Seat Maker to Stop Using Leather for Its Car Seats
• Petition: Tell the Victorian Government to Rescind Classification of Dingoes as “Unprotected Wildlife”
• Petition: Demand Disney Retire Dolphins to a Sanctuary Instead of Another Amusement Park
• Petition: Help Reduce Bat Deaths from Wind Turbines
• Petition: Urge the UN to Correctly Report on Animal Agriculture’s Emissions
• Petition: Demand That a Tiger Who Escaped a Zoo Be Sent to a Reputable Sanctuary
• Petition: Tell Microsoft to Find A Safer and More Eco-Friendly Power Station to Power Its Data Centers
• Petition: Urge Authorities in Australia to Educate the Public on How to Interact with Wildlife
• Petition: Hold ExxonMobil Accountable for Deceptive Claims About Plastic Recycling

Related Content:

• Surprise Pregnancies Rise, Potentially from Ozempic
• 10 Natural Alternatives to Ozempic
• 10 Natural Alternatives to Ozempic or Semaglutide for Managing Type 2 Diabetes
• Survey Shows Americans Prefer Diet Changes Over Weight-Loss Injections

Easy Ways to Help the Planet:

• Eat Less Meat: Download Food Monster, the largest plant-based Recipe app on the App Store, to help reduce your environmental footprint, save animals and get healthy. You can also buy a hard or soft copy of our favorite vegan cookbooks.
• Adopt-a-Pet: Visit WildWatchers, a watchdog platform specifically designed for animal, earth, and wildlife warriors to actively give back, rescue, and protect animals and the planet.
• Reduce Your Fast Fashion Footprint: Take initiative by standing up against fast fashion Pollution and supporting sustainable and circular brands like Tiny Rescue that raise awareness around important issues through recycled zero-waste clothing designed to be returned and remade over and over again.
• Support Independent Media: Being publicly funded gives us a greater chance to continue providing you with high-quality content. Please consider supporting us by donating!
• Sign a Petition: Your voice matters! Help turn petitions into victories by signing the latest list of must-sign petitions to help people, animals, and the planet.
• Stay Informed: Keep up with the latest news and important stories involving animals, the environment, sustainable living, food, health, and human interest topics by subscribing to our newsletter!
• Do What You Can: Reduce waste, plant trees, eat local, travel responsibly, reuse stuff, say no to single-use plastics, recycle, vote smart, switch to cold water laundry, divest from fossil fuels, save water, shop wisely, Donate if you can, grow your food, volunteer, conserve energy, compost, and don’t forget about the microplastics and microbeads lurking in common household and personal care products!